Literature DB >> 15340122

Subcutaneous furosemide.

Miguel A Goenaga, Manuel Millet, Eloy Sánchez, Carmen Garde, José A Carrera, Edurne Arzellus.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15340122     DOI： 10.1345/aph.1E172

Source DB:  PubMed          Journal:  Ann Pharmacother        ISSN： 1060-0280            Impact factor:   3.154


× No keyword cloud information.
  6 in total

1.  Palliative and end-of-life care for patients with chronic heart failure and chronic lung disease.

Authors:  Miriam J Johnson; Sara Booth
Journal:  Clin Med (Lond)       Date:  2010-06       Impact factor: 2.659

Review 2.  Management of end stage cardiac failure.

Authors:  Miriam J Johnson
Journal:  Postgrad Med J       Date:  2007-06       Impact factor: 2.401

Review 3.  Subcutaneous furosemide for the treatment of heart failure: a state-of-the art review.

Authors:  Maxwell Eyram Afari; Joe Aoun; Sarthak Khare; Lana Tsao
Journal:  Heart Fail Rev       Date:  2019-05       Impact factor: 4.214

4.  Dilemmas in the Dosing of Heart Failure Drugs: Titrating Diuretics in Chronic Heart Failure.

Authors:  David Pham; Justin L Grodin
Journal:  Card Fail Rev       Date:  2017-11

5.  Discomfort from an alkaline formulation delivered subcutaneously in humans: albumin at pH 7 versus pH 10.

Authors:  W Kenneth Ward; Jessica R Castle; Deborah L Branigan; Ryan G Massoud; Joseph El Youssef
Journal:  Clin Drug Investig       Date:  2012-07-01       Impact factor: 2.859

6.  Subcutaneous Furosemide in Heart Failure: Pharmacokinetic Characteristics of a Newly Buffered Solution.

Authors:  Domenic A Sica; Pieter Muntendam; Rene L Myers; Jozine M Ter Maaten; Mark E Sale; Rudolf A de Boer; Bertram Pitt
Journal:  JACC Basic Transl Sci       Date:  2018-02-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.